Anli Liu1, Trudy Pang, Susan Herman, Alvaro Pascual-Leone, Alexander Rotenberg. 1. New York University Comprehensive Epilepsy Center, 223 East 34th Street, New York, NY 10016, USA; New York University Langone Medical Center and School of Medicine, 550 First Avenue, New York, NY 10016 USA. Electronic address: anli.liu@nyumc.org.
Abstract
PURPOSE: To examine the efficacy and safety profile of antiepileptic repetitive transcranial magnetic stimulation (rTMS) for refractory status epilepticus (RSE) in the intensive care unit (ICU) setting. In addition, hypothetical concerns about electrical interference of rTMS with ICU equipment have been previously raised. METHODS: We describe two cases of RSE treated with rTMS in the ICU. RESULTS: In one case, rTMS contributed to decreased seizure frequency; in the second case, rTMS transiently decreased seizure frequency. In both cases, rTMS was safe and did not interfere with the functioning of the ICU equipment. CONCLUSION: rTMS is a potential therapy for RSE when conventional therapies have failed. Future studies should investigate the efficacy of various rTMS stimulation parameters, safety issues, and bioengineering considerations in the ICU setting.
PURPOSE: To examine the efficacy and safety profile of antiepileptic repetitive transcranial magnetic stimulation (rTMS) for refractory status epilepticus (RSE) in the intensive care unit (ICU) setting. In addition, hypothetical concerns about electrical interference of rTMS with ICU equipment have been previously raised. METHODS: We describe two cases of RSE treated with rTMS in the ICU. RESULTS: In one case, rTMS contributed to decreased seizure frequency; in the second case, rTMS transiently decreased seizure frequency. In both cases, rTMS was safe and did not interfere with the functioning of the ICU equipment. CONCLUSION: rTMS is a potential therapy for RSE when conventional therapies have failed. Future studies should investigate the efficacy of various rTMS stimulation parameters, safety issues, and bioengineering considerations in the ICU setting.
Authors: Felipe Fregni; Patricia T M Otachi; Angela Do Valle; Paulo S Boggio; Gregor Thut; Sergio P Rigonatti; Alvaro Pascual-Leone; Kette D Valente Journal: Ann Neurol Date: 2006-10 Impact factor: 10.422
Authors: A Graff-Guerrero; J Gonzáles-Olvera; M Ruiz-García; U Avila-Ordoñez; V Vaugier; J C García-Reyna Journal: Acta Neurol Scand Date: 2004-04 Impact factor: 3.209
Authors: Alexander Rotenberg; Erica Hyunji Bae; Masanori Takeoka; Jose M Tormos; Steven C Schachter; Alvaro Pascual-Leone Journal: Epilepsy Behav Date: 2008-10-30 Impact factor: 2.937
Authors: Matthew D Smyth; Rowland H Han; Chester K Yarbrough; Edward E Patterson; Xiao-Feng Yang; John W Miller; Steven M Rothman; Raimondo D'Ambrosio Journal: Ther Hypothermia Temp Manag Date: 2015-04-22 Impact factor: 1.286
Authors: Keith Starnes; Jeffrey W Britton; David B Burkholder; Iffat A Suchita; Nicholas M Gregg; Bryan T Klassen; Brian Nils Lundstrom Journal: Front Neurosci Date: 2022-06-10 Impact factor: 5.152
Authors: Marta Nowakowska; Muammer Üçal; Marios Charalambous; Sofie F M Bhatti; Timothy Denison; Sebastian Meller; Gregory A Worrell; Heidrun Potschka; Holger A Volk Journal: Front Vet Sci Date: 2022-06-16
Authors: Jimmy C Yang; Nitish M Harid; Fábio A Nascimento; Vasileios Kokkinos; Abigail Shaughnessy; Alice D Lam; M Brandon Westover; Thabele M Leslie-Mazwi; Leigh R Hochberg; Eric S Rosenthal; Andrew J Cole; Robert M Richardson; Sydney S Cash Journal: Ann Clin Transl Neurol Date: 2021-05-06 Impact factor: 4.511